Amgen, Inc. (AMGN)
366.25
+0.04
(+0.01%)
USD |
NASDAQ |
Mar 16, 16:00
366.14
-0.11
(-0.03%)
After-Hours: 20:00
Amgen Total Assets (Quarterly) : 90.59B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.44B |
| Gilead Sciences, Inc. | 59.02B |
| Johnson & Johnson | 199.21B |
| Eli Lilly & Co. | 112.48B |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 81.93B |
| Shareholders Equity (Quarterly) | 8.658B |
| Debt to Equity Ratio | 6.403 |
| Current Ratio | 1.14 |
| Net Debt Paydown Yield | 0.56% |